Prevalence of latent tuberculosis infection in German radiologists

Journal of Hospital Infection

Volumn 69, Issue 1, 2008, Pages 69-76

  Barsegian, V ^a   Mathias, K D ^a   Wrighton Smith, P ^b   Grosse Wilde, H ^c   Lindemann, M ^c  

^a KLINIKUM DORTMUND   (Germany)

^b Oxford Immunotec   (United Kingdom)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Birthplace; Healthcare worker; Latent tuberculosis infection; Lymphocyte transformation test; T SPOT.TB; Tuberculosis skin test

Indexed keywords

BCG VACCINE; TUBERCULIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSPOT ASSAY; ETHNICITY; FEMALE; GERMANY; HEALTH CARE PERSONNEL; HUMAN; IN VITRO STUDY; INCIDENCE; INFECTION RISK; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; LYMPHOCYTE TRANSFORMATION TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; OCCUPATIONAL EXPOSURE; PREVALENCE; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RADIOLOGIST; RADIOLOGY DEPARTMENT; TUBERCULIN TEST;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; HEALTH PERSONNEL; HUMANS; LATENCY PERIOD (PSYCHOLOGY); LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RADIOLOGY; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 42649129382     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2008.02.009     Document Type: Article

References (31)

1. WHO. Tuberculosis. WHO Media Centre. March 2007; factsheet no 104.
2. Robert Koch Institut (RKI). Tuberkulose. Epidemiologisches Bulletin 11 (2007) 87-93
3. Diel R., Seidler A., Nienhaus A., Rusch-Gerdes S., and Niemann S. Occupational risk of tuberculosis transmission in a low incidence area. Respir Res 6 (2005) 35-45
4. Jensen P.A., Lambert L.A., Iademarco M.F., Ridzon R., and CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings. MMWR Recomm Rep 54 (2005) 1-141
5. Huebner R.E., Schein M.F., and Bass J.B. The tuberculin skin test. Clin Infect Dis 17 (1993) 968-975
6. Black G.F., Dockrell H.M., Crampin A.C., et al. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J Infect Dis 184 (2001) 322-329
7. Chapman A.L., Munkanta M., Wilkinson K.A., et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 16 (2002) 2285-2293
8. Ewer K., Deeks J., Alvarez L., et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361 (2003) 1168-1173
9. Lalvani A., Pathan A.A., McShane H., et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 163 (2001) 824-828
10. Lalvani A., Nagvenkar P., Udwadia Z., et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 183 (2001) 469-477
11. Meier T., Eulenbruch H.P., Wrighton-Smith P., Enders G., and Regnath T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 24 (2005) 529-536
12. Pathan A.A., Wilkinson K.A., Klenerman P., et al. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 167 (2001) 5217-5225
13. Piana F., Codecasa L.R., Cavallerio P., et al. Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients. Eur Respir J 28 (2006) 31-34
14. Richeldi L., Ewer K., Losi M., et al. T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am J Respir Crit Care Med 170 (2004) 288-295
15. Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 174 (2006) 736-742
16. Zellweger J.P., Zellweger A., Ansermet S., de Senarclens B., and Wrighton-Smith P. Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test. Int J Tuberc Lung Dis 9 (2005) 1242-1247
17. Lindemann M., Böhmer J., Zabel M., and Grosse-Wilde H. ELISpot: a new tool for the detection of nickel sensitization. Clin Exp Allergy 33 (2003) 992-998
18. Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK). Von der WHO empfohlenes Tuberkulin PPD RT 23 SSI in Deutschland zugelassen. Epidemiologisches Bulletin 41 (2005) 380-381
19. Ferlinz R. Tuberkulindiagnostik. Dt Ärztebl 93A (1996) 1199-1201
20. Tissot F., Zanetti G., Francioli P., Zellweger J.P., and Zysset F. Influence of bacille Calmette-Guerin vaccination on size of tuberculin skin test reaction: to what size?. Clin Infect Dis 40 (2005) 211-217
21. Harada N., Nakajima Y., Higuchi K., Sekiya Y., Rothel J., and Mori T. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 27 (2006) 442-448
22. Nienhaus A., Schablon A., Loddenkemper R., Hauer B., Wolf N., and Diel R. [Prevalence of latent tuberculosis infection in healthcare workers in geriatric care]. Pneumologie 61 (2007) 613-616
23. Ferrara G., Losi M., D'Amico R., et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367 (2006) 1328-1334
24. Dye C., Scheele S., Dolin P., Pathania V., and Raviglione M.C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. J Am Med Assoc 282 (1999) 677-686
25. Bloom B.R., and Murray C.J. Tuberculosis: commentary on a reemergent killer. Science 257 (1992) 1055-1064
26. Richeldi L., Ewer K., Losi M., Roversi P., Fabbri L.M., and Lalvani A. Repeated tuberculin testing does not induce false positive ELISPOT results. Thorax 61 (2006) 180
27. Deutsche Gesellschaft für Krankenhaushygiene. Infektionsverhütung bei Tuberkulose in Gesundheits- und Sozialeinrichtungen. Hyg Med 10 (1997) 523-534
28. Schaberg T., Hauer B., Loddenkemper R., et al. [Latent tuberculosis infection: recommendations for preventive therapy in adults in Germany]. Pneumologie 58 (2004) 92-102
29. Wrighton-Smith P., and Zellweger J.P. Direct costs of three models for the screening of latent tuberculosis infection. Eur Respir J 28 (2006) 45-50
30. Gershon A.S., McGeer A., Bayoumi A.M., Raboud J., and Yang J. Health care workers and the initiation of treatment for latent tuberculosis infection. Clin Infect Dis 39 (2004) 667-672
31. Diel R., Forssbohm M., Loytved G., et al. German Central Committee against Tuberculosis. [Recommendations for environmental contact tracing in tuberculosis. German Central Committee against Tuberculosis]. Gesundheitswesen 69 (2007) 488-503